These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2101158)

  • 1. Anti-tetanus human monoclonal antibodies.
    Matsuda M; Kamei M; Hashizume S; Sugimoto N
    Jpn J Med Sci Biol; 1990 Dec; 43(6):272-3. PubMed ID: 2101158
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishment of stable mouse/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity.
    Kamei M; Hashizume S; Sugimoto N; Ozutsumi K; Matsuda M
    Eur J Epidemiol; 1990 Dec; 6(4):386-97. PubMed ID: 2091939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
    Matsuda M; Makinaga G; Hirai T
    Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D; Tripputi P; Roder JC; Croce CM
    J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences in the production of human monoclonal antibodies to tetanus toxoid.
    Boyd JE; Hastings I; Farzad Z; James K; McClelland DB
    Dev Biol Stand; 1984; 57():93-8. PubMed ID: 6526155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies and uveal melanomas].
    Le Rebeller MJ; Safi N; Larson S; Beba R; Kantor R; Donoso L
    Ophtalmologie; 1989; 3(3):180-2. PubMed ID: 2641105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells of immunized subjects.
    Butler JL; Lane HC; Fauci AS
    J Immunol; 1983 Jan; 130(1):165-8. PubMed ID: 6336623
    [No Abstract]   [Full Text] [Related]  

  • 10. Production and growth of hybridomas secreting monoclonal antibodies to human thyroid stimulating hormone.
    Denyer MD; Hubbard R; Marks V
    Dev Biol Stand; 1985; 60():493-501. PubMed ID: 4043540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine.
    Isaka M; Komiya T; Takahashi M; Yasuda Y; Taniguchi T; Zhao Y; Matano K; Matsui H; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2004 Aug; 22(23-24):3061-8. PubMed ID: 15297056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T; Kato K; Shiku H; Yamada K
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The preparation and identification of anti-erythropoietin monoclonal antibodies].
    Jiang M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):138-42. PubMed ID: 8242822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal anti-Rh antibodies produced by human-mouse heterohybridomas express the Gal alpha 1-3 Gal epitope.
    Montaño RF; Romano EL
    Hum Antibodies Hybridomas; 1994; 5(3-4):152-6. PubMed ID: 7538807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study of the problem of the immunizability of the aged. I. Active anti-tetanus immunization experiments].
    Del Campo A; Franzoni A; Pasqualicchio A; Tomasi A
    Ann Sanita Pubblica; 1970; 31(1):23-36. PubMed ID: 4103067
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphocyte hybridomas: monoclonal antibodies and more.
    LeBlanc PA
    Year Immunol; 1986; 2():187-94. PubMed ID: 3033944
    [No Abstract]   [Full Text] [Related]  

  • 18. A hollow fibre dialysis system for the in vitro production of monoclonal antibodies replacing in vivo production in mice.
    Schönherr OT; van Gelder PT; van Hees PJ; van Os AM; Roelofs HW
    Dev Biol Stand; 1987; 66():211-20. PubMed ID: 3582749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in the development of human monoclonal antibodies.
    Jahn S; Grunow R; Kiessig ST; Settmacher U; Von Baehr R
    Dev Biol Stand; 1990; 71():3-7. PubMed ID: 2401386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human monoclonal antibodies directed to lung cancer].
    Kudo T
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):363-8. PubMed ID: 8109992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.